sábado, 1 de abril de 2017

Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement

Continued CDC Funding for States to Detect, Respond, Prevent and Innovate

AR Investment Map to DHQP External Partners

Through CDC’s Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement, CDC continues to work with state and local health departments to implement tracking, prevention, and antibiotic stewardship activities -- transforming how the nation combats and slows antibiotic resistance at all levels.
In addition to investments made last year, CDC is inviting grantees to participate in enhanced activities, potentially including:
  • An Antibiotic Resistance Lab Network regional lab focused on drug-resistant tuberculosis
  • Increased testing nationwide for the fungal threat Candida, including C. auris
  • Whole genome sequencing for resistant gonorrhea isolates
These activities will enhance capacities to rapidly detect antibiotic resistance and prevent its spread to better protect Americans. Visit CDC’s antibiotic resistance website for the funding announcement.
See how CDC invested in every state in 2016 to combat antibiotic resistance in healthcare facilities, the community, and food.
Local CDC investments through ELC combat antibiotic resistance by strengthening the public health workforce and building stronger surveillance systems, modern and efficient laboratory facilities, and more integrated health information networks.

No hay comentarios: